These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19881388)

  • 1. Abdominal obesity and subclinical vascular damage in the elderly.
    Fantin F; Di Francesco V; Rossi A; Giuliano K; Marino F; Cazzadori M; Gozzoli MP; Vivian ME; Bosello O; Rajkumar C; Zamboni M
    J Hypertens; 2010 Feb; 28(2):333-9. PubMed ID: 19881388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the metabolic syndrome and its components combinations on arterial stiffness in Type 2 diabetic men.
    Levisianou D; Melidonis A; Adamopoulou E; Skopelitis E; Koutsovasilis A; Protopsaltis I; Zairis M; Kougialis S; Skoularigis I; Koukoulis G; Foussas S; Triposkiadis F
    Int Angiol; 2009 Dec; 28(6):490-5. PubMed ID: 20087288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and arterial stiffness: the Health 2000 Survey.
    Sipilä K; Koivistoinen T; Moilanen L; Nieminen T; Reunanen A; Jula A; Salomaa V; Kaaja R; Kööbi T; Kukkonen-Harjula K; Majahalme S; Kähönen M
    Metabolism; 2007 Mar; 56(3):320-6. PubMed ID: 17292719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events.
    Mancia G; Bombelli M; Facchetti R; Casati A; Ronchi I; Quarti-Trevano F; Arenare F; Grassi G; Sega R
    J Hypertens; 2010 May; 28(5):999-1006. PubMed ID: 20308922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese.
    Cheung BM; Wat NM; Tam S; Thomas GN; Leung GM; Cheng CH; Woo J; Janus ED; Lau CP; Lam TH; Lam KS
    Clin Endocrinol (Oxf); 2008 May; 68(5):730-7. PubMed ID: 17980012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral fat and subclinical vascular damage in older women.
    Fantin F; Rossi AP; Cazzadori M; Comellato G; Mazzali G; Gozzoli MP; Grison E; Zamboni M
    Age Ageing; 2013 May; 42(3):359-65. PubMed ID: 23449599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
    Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
    J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO.
    Ma WY; Li HY; Hung CS; Lin MS; Chiu FC; Lin CH; Shih SR; Chuang LM; Wei JN
    Diabetes Res Clin Pract; 2009 Sep; 85(3):335-41. PubMed ID: 19608293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study.
    Yoon YS; Lee ES; Park C; Lee S; Oh SW
    Int J Obes (Lond); 2007 Mar; 31(3):528-34. PubMed ID: 16865099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome.
    Dupuy AM; Jaussent I; Lacroux A; Durant R; Cristol JP; Delcourt C
    Gerontology; 2007; 53(6):329-39. PubMed ID: 17551260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of criteria for metabolic syndrome in a population-based study of Japanese-Brazilians.
    Rosenbaum P; Gimeno SG; Sanudo A; Franco LJ; Ferreira SR;
    Diabetes Obes Metab; 2005 Jul; 7(4):352-9. PubMed ID: 15955121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of metabolic syndrome on arterial stiffness and wave reflections: focus on distinct definitions.
    Vyssoulis GP; Pietri PG; Karpanou EA; Vlachopoulos CV; Kyvelou SM; Spanos P; Cokkinos DV; Stefanadis CI
    Int J Cardiol; 2010 Jan; 138(2):119-25. PubMed ID: 18804878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and interrelationships between cardio-metabolic risk factors in abdominally obese individuals.
    Pettman TL; Buckley JD; Coates AM; Misan GM; Petkov J; Howe PR
    Metab Syndr Relat Disord; 2009 Feb; 7(1):31-6. PubMed ID: 19025446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome may be associated with increased arterial stiffness even in the absence of hypertension: a study in 84 cases and 82 controls.
    Kangas P; Tikkakoski AJ; Tahvanainen AM; Leskinen MH; Viitala JM; Kähönen M; Kööbi T; Niemelä OJ; Mustonen JT; Pörsti IH
    Metabolism; 2013 Aug; 62(8):1114-22. PubMed ID: 23557592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.